Danaher Corporation vs TJX Companies Inc — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while TJX Companies Inc trades at $138.76 (market cap $152.62B). The key difference: Danaher Corporation and TJX Companies Inc are close in size by market cap, and TJX Companies Inc pays the higher dividend (1.38%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and TJX Companies Inc for 97 Days on average.
| DHR | TJX | |
|---|---|---|
Market Cap | $152.87B | $152.62B |
Volume | 5,228,698 | 8,079,794 |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $168.41 |
52-Week Low | $161.91 | $122.84 |
Typical Hold Time | 69 Days | 97 Days |
Enterprise Value | $175.08B | $160.93B |
Dividend Yield | 0.74% | 1.38% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
TJX trades at $138.75, down 0.04% on the day, with strong fundamental performance including 62.17% ROE and consistent earnings beats. The stock shows bullish technical momentum with support at $136 and resistance at $140. Revenue grew to $56.36B in 2025 with net income reaching $4.86B, while analyst consensus remains overwhelmingly positive with 85% buy ratings.
TJX presents a compelling investment case with projected 28% upside to the $174.15 consensus target, supported by expanding profit margins and robust cash flow generation. Key risks include competitive pressures in off-price retail and potential consumer spending volatility. The company's strong balance sheet and consistent dividend payments provide stability amid market fluctuations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →